Biotronik inked a US-based co-distribution deal with Aziyo Biologics to distribute the company’s CanGaroo bio-envelopes designed to hold cardiovascular implantable devices, according to a release from Aziyo posted today.
Silver Spring, Md.-based Aziyo Biologic’s CanGaroo bio envelope is designed to reduce the risk of device migration and erosion and simplify device removal during revisions or exchanges, the company said. The system is available in five sizes and are made out of a natural extracellular matrix.
“Biotronik is trusted and respected by hospitals, physicians and patients, and our distribution partnership expands access to a meaningful cardiovascular solution. Our ECM envelopes help deliver the best possible patient care and can reduce cost, providing advantages that complement Biotronik’s comprehensive portfolio of cardiac rhythm management devices. This partnership changes the landscape of cardiac care,” Aziyo cardiovascular products GM Andrew Green said in a press release.
Biotronik said it began offering the CanGaroo in the US this month, branded as the Bio Envelope.
“At Biotronik, quality patient outcomes are our utmost priority. Our partnerships with hospitals to reduce cost exemplify our commitment to value-based care. That is why our partnership with Aziyo, a proven regenerative medicine company, is so important. It’s a partnership that will significantly improve patient care,” Biotronik prez Marlou Janssen said in a prepared statement.